Importance of PET with 68Ga-Labeled Somatostatin Analogs.

Abstract

Neuroendocrine tumors (NETs) still represent a diagnostic challenge because their clinical presentation is often nonspecific and usually occurs late in the disease, when metastases are already present ([1][1]). Imaging modalities such as CT, MRI, and transabdominal ultrasound are fundamental for